Showing 7561-7570 of 8649 results for "".
- Johnson & Johnson Takes Charge of Emergent COVID-19 Vaccine Manufacturing Sitehttps://modernod.com/news/johnson-johnson-takes-charge-of-emergent-covid-19-vaccine-manufacturing-site/2479052/The US Department of Health & Human Services (HHS) has put Johnson & Johnson in charge of the Emergent BioSolutions’ Bayview facility in Baltimore, which ruined around 15 million doses of its COVID-19 vaccine Ad26.COV2.S. Johnson & Johnson said it was “assuming full
- Oxurion Enters Into a Capital Commitment of Up to €30 Million With Negma Grouphttps://modernod.com/news/oxurion-enters-into-a-capital-commitment-of-up-to-e30-million-with-negma-group/2479054/Oxurion announced that is has agreed to a capital commitment of up to €30 Million with Paris-based financial institution Negma Group. Negma Group has committed to subscribe to up to €30 million in equity in tranches over a 12-month period through mandatory convertible bonds at Oxurion’s sole dis
- David R. Guyer, MD, to Step Down from Iveric Bio Board to Rejoin Venture Fundhttps://modernod.com/news/david-r-guyer-md-to-step-down-from-iveric-bio-board-to-rejoin-venture-fund/2479050/Iveric bio announced that David R. Guyer, MD, co-founder and Executive Chairman, is stepping down from the Iveric Bio Board after 14 years, effective following Iveric Bio’s 2021 Annual Stockholder Meeting scheduled to be held on May 19, 2021. Dr. Guyer has served as the Chairman of Iveric’
- Nursing Homes See 96 Percent Decline In COVID Cases Since Vaccine Rollouthttps://modernod.com/news/nursing-homes-see-96-percent-decline-in-covid-cases-since-vaccine-rollout/2479027/The American Health Care Association and National Center for Assisted Living (AHCA/NCAL), which represents more than 14,000 nursing homes and long term care facilities across the US, released a
- Pfizer, Moderna COVID-19 Vaccines Show High Efficacy in First US Real-World Studyhttps://modernod.com/news/pfizer-moderna-covid-19-vaccines-show-high-efficacy-in-first-us-real-world-study/2479028/New data released Monday from a US Centers for Disease Control and Prevention (CDC) study of vaccinated health care workers show that mRNA-based coronavirus vaccines by Pfizer and Moderna were 80% effective at preventing infections after one dose, with efficacy climbing to 90% 2 weeks after the s
- EU Regulator Clears Manufacturing Sites to Boost COVID-19 Vaccine Supplyhttps://modernod.com/news/eu-regulator-clears-manufacturing-sites-to-boost-covid-19-vaccine-supply/2479025/The European Medicines Agency (EMA) said it adopted several actions aimed at boosting COVID-19 vaccine production and rollout in the EU. These include clearing the Halix production site in Leiden, the Netherlands that makes AstraZeneca’s vaccine AZD1222, as well as another facility located
- Pfizer, BioNTech Initiate Study of COVID-19 Vaccine in Children Under 12https://modernod.com/news/pfizer-biontech-initiate-study-of-covid-19-vaccine-in-children-under-12/2479017/Pfizer and BioNTech said Thursday that they have started testing their COVID-19 vaccine BNT162b2 in children ages 6 months to 11 years old, with initial results expected in the second half of the year. The mRNA-based vaccine is currently authorized for people 16 years and older in multiple market
- Visus Therapeutics Initiates Phase 2 Clinical Trial of Brimochol for the Treatment of Presbyopiahttps://modernod.com/news/visus-therapeutics-initiates-phase-2-clinical-trial-of-brimochol-for-the-treatment-of-presbyopia/2479013/Visus Therapeutics announced the commencement of its phase 2 clinical trial of Brimochol topical ophthalmic solution under investigation for the treatment of presbyopia. Brimochol is a proprietary pupil-modulating eye drop that combines two well-studied, FDA-approved pharmaceuticals: carb
- Steady Growth, New Technologies Will Drive Retinal Surgery Device Market to $1.36 Billion by 2026https://modernod.com/news/steady-growth-new-technologies-will-drive-retinal-surgery-device-market-to-1-36-billion-by-2026/2479005/The retinal surgical device market is expected to total more than $1.14 billion in 2021, with revenue rising to nearly $1.36 billion in 2026, according to a Market Scope report. Retina surgery device sales are driven almost entirely by vitrectomy, a procedure which involves removal of the
- Judy F. Gordon, DVM, Founder of ClinReg Consulting Services, Retireshttps://modernod.com/news/judy-f-gordon-dvm-founder-of-clinreg-consulting-services-retires/2479004/Medical device and pharmaceutical consulting company ClinReg Consulting Services announced the retirement of its founder and president, Judy F. Gordon, DVM. Dr. Gordon has worked in the clinical and regulatory industry for more than 35 years, beginning with her career in the pharmaceutical